Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome (Q33389149)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome |
scientific article |
Statements
1 reference
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome (English)
1 reference
Bob Lowenberg
1 reference
Pau Montesinos
1 reference
Chelo Rayón
1 reference
Alexandra Holowiecka
1 reference
Gustavo Milone
1 reference
Elena de Lisa
1 reference
Salut Brunet
1 reference
Vicente Rubio
1 reference
José M Ribera
1 reference
Concha Rivas
1 reference
Isabel Krsnik
1 reference
Juan Bergua
1 reference
José González
1 reference
Joaquín Díaz-Mediavilla
1 reference
Rafael Rojas
1 reference
Félix Manso
1 reference
Gert Ossenkoppele
1 reference
José D González
1 reference
PETHEMA and HOVON Groups
1 reference
Identifiers
1 reference